Literature DB >> 22949783

Hyperinsulinemia euglycemia therapy for calcium channel blocker overdose: a case report.

Anushree Agarwal1, Siegfried W Yu, Abdul Rehman, Joseph Q Henkle.   

Abstract

We report the case of a patient with calcium channel blocker toxicity who was treated successfully with hyperinsulinemia euglycemia therapy, without prior use of vasopressors. The patient was a 60-year-old man with schizoaffective disorder who presented with severe hemodynamic compromise after an intentional overdose of 5,400 mg of extended-release diltiazem. He had been admitted to the hospital twice before for attempted suicide with diltiazem and nifedipine, respectively. During the previous admissions, conventional treatments were used, and complications included hemodynamic compromise, ischemic bowel requiring ileostomy, and a prolonged hospital stay. During the current admission, the patient's clinical condition failed to improve after treatment with charcoal, fluid resuscitation, calcium, and glucagon. Eight hours after admission, hyperinsulinemia euglycemia therapy was initiated; 3 hours later, the patient's hemodynamic status showed sustained improvement. His bradycardia and hypotension resolved without cardiac pacing or vasopressors. Hyperinsulinemia euglycemia therapy is a potentially life-saving treatment for calcium channel blocker toxicity. We suggest that such therapy should be considered early, in conjunction with conventional therapy, for the treatment of calcium channel blocker overdose in patients not responding to initial treatment.

Entities:  

Keywords:  Calcium channel blockers; diltiazem; hyperinsulinemia euglycemia therapy; insulin/therapeutic use

Mesh:

Substances:

Year:  2012        PMID: 22949783      PMCID: PMC3423274     

Source DB:  PubMed          Journal:  Tex Heart Inst J        ISSN: 0730-2347


  16 in total

1.  Hyperinsulinemia/euglycemia therapy for calcium channel blocker poisoning.

Authors:  Edward W Boyer; Peter A Duic; Adelaide Evans
Journal:  Pediatr Emerg Care       Date:  2002-02       Impact factor: 1.454

Review 2.  High-dose insulin therapy for calcium-channel blocker overdose.

Authors:  Greene Shepherd; Wendy Klein-Schwartz
Journal:  Ann Pharmacother       Date:  2005-04-05       Impact factor: 3.154

3.  2009 Annual Report of the American Association of Poison Control Centers' National Poison Data System (NPDS): 27th Annual Report.

Authors:  Alvin C Bronstein; Daniel A Spyker; Louis R Cantilena; Jody L Green; Barry H Rumack; Sandra L Giffin
Journal:  Clin Toxicol (Phila)       Date:  2010-12       Impact factor: 4.467

4.  Insulin-glucose as adjunctive therapy for severe calcium channel antagonist poisoning.

Authors:  T H Yuan; W P Kerns; C A Tomaszewski; M D Ford; J A Kline
Journal:  J Toxicol Clin Toxicol       Date:  1999

5.  Rational pharmacotherapy of hypertension in the elderly: analysis of the choice and dosage of drugs.

Authors:  K A Jassim Al Khaja; R P Sequeira; V S Mathur
Journal:  J Clin Pharm Ther       Date:  2001-02       Impact factor: 2.512

Review 6.  Treatment of calcium channel blocker intoxication with insulin infusion: case report and literature review.

Authors:  Maria Marques; Ernestina Gomes; Júlio de Oliveira
Journal:  Resuscitation       Date:  2003-05       Impact factor: 5.262

7.  Electrophysiologic effects of amlodipine vs. diltiazem in patients with coronary artery disease and beta-blocking therapy.

Authors:  P Santarelli; F Biscione; A Natale; A Manzoli; G A Lanza
Journal:  Cardiovasc Drugs Ther       Date:  1994-08       Impact factor: 3.727

8.  Beneficial myocardial metabolic effects of insulin during verapamil toxicity in the anesthetized canine.

Authors:  J A Kline; E Leonova; R M Raymond
Journal:  Crit Care Med       Date:  1995-07       Impact factor: 7.598

9.  Insulin is a superior antidote for cardiovascular toxicity induced by verapamil in the anesthetized canine.

Authors:  J A Kline; C A Tomaszewski; J D Schroeder; R M Raymond
Journal:  J Pharmacol Exp Ther       Date:  1993-11       Impact factor: 4.030

10.  Severe intoxication after an intentional overdose of amlodipine.

Authors:  L Rasmussen; S E Husted; S P Johnsen
Journal:  Acta Anaesthesiol Scand       Date:  2003-09       Impact factor: 2.105

View more
  3 in total

Review 1.  Management of Calcium Channel Blocker Toxicity in the Pediatric Patient.

Authors:  Jenna W Bartlett; Pamela L Walker
Journal:  J Pediatr Pharmacol Ther       Date:  2019 Sep-Oct

2.  Severe diltiazem poisoning treated with hyperinsulinaemia-euglycaemia and lipid emulsion.

Authors:  Nadine Monteiro; Joana Silvestre; João Gonçalves-Pereira; Camila Tapadinhas; Vitor Mendes; Pedro Póvoa
Journal:  Case Rep Crit Care       Date:  2013-05-20

Review 3.  Treatment for calcium channel blocker poisoning: a systematic review.

Authors:  M St-Onge; P-A Dubé; S Gosselin; C Guimont; J Godwin; P M Archambault; J-M Chauny; A J Frenette; M Darveau; N Le Sage; J Poitras; J Provencher; D N Juurlink; R Blais
Journal:  Clin Toxicol (Phila)       Date:  2014-10-06       Impact factor: 4.467

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.